A 62-year-old with T2D has A1C 8.4% on metformin 1,000 mg BID and empagliflozin 10 mg daily; BMI 33; ASCVD present. Next agent to improve glycemia and...

Question

A 62-year-old with T2D has A1C 8.4% on metformin 1,000 mg BID and empagliflozin 10 mg daily; BMI 33; ASCVD present. Next agent to improve glycemia and CV risk?

Accepted Answer

Add GLP-1 receptor agonist with CV benefit

Answer

Add sulfonylurea

Answer

Add DPP-4 inhibitor

Answer

Switch metformin to pioglitazone

Answer

Start premixed insulin

us-abim MCQ (SBA): Type 2 Diabetes Therapy

A 62-year-old with T2D has A1C 8.4% on metformin 1,000 mg BID and empagliflozin 10 mg daily; BMI 33; ASCVD present. Next agent to improve glycemia and CV risk?